Many US adolescents are regularly exposed to ∆ 9 -tetrahydrocannabinol (THC) via the smoking and more recently, vaping, of cannabis and cannabis extracts. Growing legalization of cannabis for medical and recreational purposes, and decreasing perceptions of harm, make it increasingly important to determine the consequences of frequent adolescent exposure.
Introduction
Significant numbers of US adolescents are exposed to ∆ 9 -tetrahydrocannabinol (THC) on a regular basis via the smoking and, more recently vaping, of cannabis and/or cannabis extracts. Data from the Monitoring the Future survey confirm that 5-6% of 12 th grade students use cannabis nearly daily and 13.9%
have used in the past month (Miech et al, 2018) . About 10% of 12 th grade students have vaped cannabis at least once in the past year and 5% in the past month (ibid). Furthermore, growing legalization of cannabis use for medical and recreational purposes, and a decreasing perception of harm, suggests these populations will only grow in coming years. It is therefore of significant interest to determine the consequences of frequent adolescent exposure to THC.
Repeated treatment of adolescent rats with THC by injection results in observable lasting effects in adulthood including decreased bodyweight (Rubino et al, 2008) , impaired spatial working memory (Rubino et al, 2009) , increased heroin self-administration (Ellgren et al, 2007) , increased reinstatement of heroin seeking after a pharmacological stressor (Stopponi et al, 2014) and greater sensitivity to learning impairment produced by acute THC (Winsauer et al, 2011) . This shows the potential risks of repeated THC exposure, however, prior investigations have primarily employed the injected route of administration (Cha et al, 2007; Ellgren et al, 2007; Rubino et al, 2008; Winsauer et al, 2011) which may not match the human condition very well. For example, the duration of effect of THC on, e.g., hypothermia, in the rat lasts hours longer following i.p. administration compared to a vapor inhalation regimen that produces a similar temperature nadir and peak plasma THC levels (Nguyen et al, 2016a; Taffe et al, 2015) . Thus, the route of administration of THC may be critical to the overall outcome. The majority of human use of cannabis is via inhalation which entails, comparatively, a more rapid onset and offset with a shorter overall duration of activity. Thus, the study of inhaled delivery of cannabis constituents in rodent models may support improved translational inferences.
The goal of this study was first to determine if vapor inhalation of THC reduces body temperature during adolescence in the rat. The e-cigarette based model has been validated previously only in adult rats (Javadi-Paydar et al, 2018; Nguyen et al, 2016a) and therefore basic efficacy in adolescents needed to be established. The second, and major, goal was to determine if twice daily THC over consecutive days in adolescence produces tolerance, which is a key initial indicator of THC exposure sufficient to induce lasting changes in the central nervous system. Our recent study in adult rats showed tolerance to the hypothermic and antinociceptive responses to THC after twice (female) or thrice (male or female) daily inhalation .The third goal was to test the hypothesis that the development of tolerance differs across rat sex, since prior work has shown that female rats develop tolerance more rapidly and at a lower mg/kg adjusted dose following twice-daily parenteral injection of relatively high THC doses (Wakley et al, 2014) . Our prior work
shows that male and female adult rats achieve similar plasma THC levels after identical inhalation conditions (Javadi-Paydar et al, 2018) but that female rats become tolerant with less intensive THC exposure compared with males . Thus it was hypothesized that the female adolescent rats would be more sensitive than the males, developing tolerance more rapidly and more completely. A final goal was to determine if there were lasting consequences of repeated adolescent THC inhalation in the adult rat in terms of tolerance to acute THC exposure, alterations in weight gain and feeding behavior (Sofia and Barry, 1974) and the propensity to self-administer an opioid drug, oxycodone, as has previously been reported for heroin (Ellgren et al, 2007; Stopponi et al, 2014) .
Methods

Subjects:
Female (N=24) and male (N=48) Wistar rats (Charles River) were shipped from the vendor on postnatal day (PND) 19 and entered the laboratory at PND 22. Rats were housed in humidity and temperaturecontrolled (23±2 °C) vivaria on 12:12 hour light:dark cycles and all studies were conducted in the rats' scotophase. Animals had ad libitum access to food and water in their home cages. Gelatin nutritional support (DietGel® Recovery, ClearH2O, Westbrook, ME, USA) was provided weekdays PND 32-46. All procedures were conducted under protocols approved by the Institutional Care and Use Committee of The Scripps
Research Institute.
Radio-telemetry:
Rats (N=16 per sex) were implanted with sterile radio-telemetry transmitters (Data Sciences
International, St Paul, MN; TA11TA-F20) in the abdominal cavity as previously described Wright et al, 2012) on PND 25. Animals were recorded in either the vapor inhalation chambers (male rats) or in separate clean home cages (female rats) in a dark testing room, separate from the vivarium. This difference in procedure means that a 30 minute recording time point was available for male rats but not for female rats.
Radiotelemetry transmissions were collected via telemetry receiver plates (Data Sciences International, St Paul, MN; RPC-1 or RMC-1) placed under the cages as described in prior investigations (Aarde et al, 2013; Miller et al, 2013; Wright et al, 2012) . The order and details of studies are outlined in Table 1 .
Drugs: ∆
9
-tetrahydrocannabinol (THC) was administered by vapor inhalation with doses described by the concentration in the propylene glycol (PG) vehicle, puff schedule and duration of inhalation sessions. The THC was provided by the U.S. National Institute on Drug Abuse and the PG was obtained from Sigma-Aldrich Corporation (St. Louis, MO, USA).
Inhalation procedure: The inhalation procedure followed methods that have been recently described (JavadiPaydar et al, 2018; Nguyen et al, 2016a) . Sealed exposure chambers were modified from the 259mm X China) by MedPC IV software (Med Associates, St. Albans, VT USA) were used for THC exposure in the groups destined for the pharmacokinetic and oxycodone self-administration experiments. The chamber air was vacuum-controlled by a chamber exhaust valve (i.e., a "pull" system) to flow room ambient air through an intake valve at ~1 L per minute. This also functioned to ensure that vapor entered the chamber on each device triggering event. The vapor stream was integrated with the ambient air stream once triggered. For all studies the system delivered four 10-s vapor puffs, with 2-s intervals, every 5 minutes for 30 minutes.
Feeding procedure: To begin a test day, all chow was removed at the start of the dark cycle in the vivarium.
Rats were moved to a procedure room, weighed and placed individually in separate rat cages equipped with Jstyle hanging chow dispensers (Guinea Pig Feeder; Ancare, Bellmore, NY, USA) starting 2 h into the dark period. Chow was removed and weighed every 2 hours for 6 hours; rats were weighed again at the end of the test interval. Pharmacokinetics: Separate groups (N=8) of male and female rats were received on PND 22 and received a single inhalation session (THC 100 mg/mL; 30 minutes) on PND 31, after which a blood sample (~500 uL) was obtained by acute venipuncture under inhalation anesthesia. The rats then received twice daily inhalation sessions from PND 36-39, as in the above experiment, with a second blood sample obtained after the first session on PND 39. This timing was designed to capture the first session of complete tolerance observed in the female rats in the telemetry study. Blood samples were also obtained from these groups on PND 86 following a THC 100 mg/mL (30 minutes) inhalation session and on PND 100 and 107 following THC 50 or 200 mg/mL inhalation for 30 minutes in a counterbalanced order.
Blood samples were collected (~500 ul) via jugular needle insertion under anesthesia with an isoflurane/oxygen vapor mixture (isoflurane 5% induction, 1-3% maintenance) 35 minutes post-initiation of vapor inhalation. Plasma THC content was quantified using fast liquid chromatography/mass spectrometry (LC/MS) adapted from (Irimia et al, 2015; Lacroix and Saussereau, 2012; Nguyen et al, 2018) . 5 μL of plasma were mixed with 50 μL of deuterated internal standard (100 ng/mL CBD-d3 and THC-d3; Cerilliant), and cannabinoids were extracted into 300 μL acetonitrile and 600 μL of chloroform and then dried. Samples were reconstituted in 100 μL of an acetonitrile/methanol/water (2:1:1) mixture. Separation was performed on an Agilent LC1100 using an Eclipse XDB-C18 column (3.5um, 2.1mm x 100mm) using gradient elution with water and methanol, both with 0.2 % formic acid (300 μL/min; 73-90%). Cannabinoids were quantified using an Intravenous Catheterization. Rats were anesthetized with an isoflurane/oxygen vapor mixture (isoflurane 5% induction, 1-3% maintenance) and prepared with chronic indwelling intravenous catheters as described previously (Aarde et al, 2017; Miller et al, 2015; Nguyen et al, 2016b) . Briefly, the intravenous catheters consisted of a 14.5-cm length of polyurethane based tubing (Micro-Renathane®, Braintree Scientific, Inc, Braintree, MA) fitted to a guide cannula (Plastics One, Roanoke, VA) curved at an angle and encased in dental cement anchored to an ~3 cm circle of durable mesh. Catheter tubing was passed subcutaneously from the animal's back to the right jugular vein. Catheter tubing was inserted into the vein and tied gently with suture thread. A liquid tissue adhesive was used to close the incisions (3M™ Vetbond™ Tissue Adhesive: 1469SB, 3M, St. Paul, MN). A minimum of 4 days was allowed for surgical recovery prior to starting an experiment. For the first three days of the recovery period, an antibiotic (cefazolin) and an analgesic (flunixin) were administered daily. During testing and training, intravenous catheters were flushed with ~0.2-0.3 ml heparinized (166.7 USP/ml) saline before sessions and ~0.2-0.3 ml heparinized saline containing cefazolin (100 mg/mL) after sessions. Catheter patency was assessed once a week after the last session of the week, via administration through the catheter of ~0.2 ml (10 mg/ml) of the ultra-short-acting barbiturate anesthetic
Brevital sodium (1% methohexital sodium; Eli Lilly, Indianapolis, IN). Animals with patent catheters exhibit prominent signs of anesthesia (pronounced loss of muscle tone) within 3 sec after infusion. Animals that failed to display these signs were considered to have faulty catheters, and if catheter patency failure was detected, data that were collected after the previous passing of this test were excluded from analysis.
Oxycodone Self-Administration: Intravenous self-administration was conducted in operant boxes (Med Associates) located inside sound-attenuating chambers located in an experimental room (ambient temperature 22 ± 1 °C; illuminated by red light) outside of the housing vivarium. To begin a session, the catheter fittings on the animals' backs were connected to polyethylene tubing contained inside a protective spring suspended into the operant chamber from a liquid swivel attached to a balance arm. Each operant session started with the extension of two retractable levers into the chamber. Following each completion of the response requirement (response ratio), a white stimulus light (located above the reinforced lever) signaled delivery of the reinforcer and remained on during a 20-sec post-infusion timeout, during which responses were recorded but had no scheduled consequences. Drug infusions were delivered via syringe pump. The training dose (0.15 mg/kg/infusion; ~0.1 ml/infusion) was selected from prior oxycodone self-administration studies Wade et al, 2015) . The rats (N=12 per group) were trained in 8 h sessions using a Fixed Ratio 1 response contingency during weekdays (5 days per week).
In the PR paradigm, the required response ratio was increased after each reinforcer delivery within a session (Hodos, 1961; Segal and Mandell, 1974) Results:
THC-induced hypothermia in adolescent rats
The initial experiment confirmed that vapor inhalation of THC induces hypothermia in adolescent rats of each sex (Figure 1A, B) . Furthermore, the male and female groups destined for repeated-THC versus 
Effect of repeated THC or PG inhalation on hypothermia in adolescent rats
There were no changes in the body temperature of the repeated-PG groups across the recording interval for any of the recording days (Supplemental Figure S1) . The male and female rats in the repeated-THC groups became hypothermic following inhalation during each of the chronic exposure weeks (Figure 2) . progressive tolerance to hypothermia developed in the female rats across the first 4 days of exposure with no hypothermia observed on days 4 and 5. The post hoc test also confirmed that significant tolerance developed in Days 3-5 relative to Day 1 in the males, although this was limited to the 120-180 minute time points. In Week 2, the post hoc test confirmed a significant reduction in body temperature relative to the PG day 60 minutes after the start of inhalation on Days 7-9 for the female rats and Days 6-10 for the male rats. Follow up analysis was conducted on the temperature recorded 60 minutes after the start of inhalation for repeated-THC cohorts of each sex to directly compare the magnitude of hypothermia across days and sex (Figure 3) . The ANOVA confirmed a main effect of day [F(11,154) 
Adult THC inhalation
Tolerance to the hypothermic effects of THC inhalation persisted into adulthood in the repeated-THC groups (Figure 4) . The statistical analysis of the temperature of the repeated PG females after inhalation during adulthood confirmed a significant effect of Time after vapor initiation [F(8,56) difference between the groups in the THC 100 mg/mL condition.
Figure 5: A, B) Mean (±SEM) plasma THC levels from female and male rats (N=8 per group) exposed to THC (100 mg/mL) vapor from PND 31-44 (A) or to THC (50-200 mg/mL) from PND 86-107 (C). Corresponding body weights are presented for the adolescent (B) and adult (D) age intervals. A significant sex difference is indicated with *, a difference from the Acute condition across groups is indicated with & and a difference from the 50 mg/mL condition with #.
Pharmacokinetic experiment
The plasma THC levels did not differ between adolescent male and female rats in either the acute or chronic samples (Figure 5) there were significant differences in weight across all three days of the adolescent and adult age ranges for each sex. 
Adult food consumption
Feeding was assessed in 6 h sessions during PND 154-158 and PND 161-165 in the males and during PND 105-109, PND 168-172 and PND 175-179 in the female rats (Figure 6) . One of the female rats from the original THC group was in apparently unrelated ill health and was not included in the PND 168-179 feeding study. The male THC group consumed more chow than the male PG Group with the analysis confirming i.p 
.). A significant difference from the first session is indicated by &. A significant difference from 0.006 mg/kg/infusion is indicated with * and a difference from the 0.06 is indicated with #.
Oxycodone self-administration in adulthood
Rats that were exposed to repeated vapor inhalation of either THC or PG vehicle during adolescence significantly escalated their oxycodone self-administration during 17 sessions of acquisition training as adults [F(16,352)=20.37; p<0.0001] ; there was no significant effect of Group ( Figure 7A) . Both groups exhibited a significant increase in appropriate drug-lever responding (lever discrimination) across sessions ( Figure 7B) Figure 7C) . Similarly, analysis of the breakpoints under PR confirmed a significant effect of Dose [F(2, 42)=11.31; p=0.0001] but no effect of Group ( Figure 7D ).
Discussion
This study showed that an e-cigarette based method of ∆
9
-tetrahydrocannabinol (THC) inhalation produces tolerance in adolescent rats with repeated exposure. Specifically, adolescent rats of each sex became hypothermic after vapor inhalation of THC, however, repeated inhalation produced rapid tolerance in the female adolescents and a delayed tolerance in both sexes when assessed as adults. This was the case during two weeks (M-F) of twice daily exposure to an inhalation regimen that produced equivalent plasma levels of THC across the sexes (Figure 5A) , thus confirming the enhanced sensitivity of female rats to the acute development of tolerance given a similar exposure to THC. In addition, tolerance to the thermoregulatory effects of inhaled THC lasted long past the chronic regimen, since adults of each sex from the repeated-THC groups were less sensitive to THC-induced hypothermia compared with their respective repeated-PG control groups when evaluated on PND 86 (Figure 4) . The tolerance was dose-specific in each sex since an increase in the THC concentration resulted in a similar hypothermia in each adolescent treatment Group. Relatedly, there was a sex difference in the tolerance threshold during adulthood, i.e., the concentration of THC which produced minimal hypothermia in the repeated-THC group but a significant response in the repeated-PG group. This dose-effect difference may have been due to a sex difference in exposure to THC during adulthood, particularly at lower inhalation dose conditions (Figure 5) .
The THC-induced temperature change in the repeated-PG groups was lesser on PND 86 compared with PND 31, potentially due to the maturation of the rats and improved thermoregulation. This interpretation is consistent with the fact that body temperature observed 60 min after the start of inhalation on PND 86 was nearly identical to that observed in groups of naïve adult Wistar rats of the respective sexes following 30 min inhalation of THC (100 mg/mL) with no exposure during adolescence (Javadi-Paydar et al, 2018) . As with our prior studies (Javadi-Paydar et al, 2018; Nguyen et al, 2016a) , spontaneous locomotor behavior was not consistently affected by repeated THC. THC vapor inhalation increased activity rates slightly for about 30 min after inhalation ceased, and some tolerance to this appeared to be present in the female rats during the second week (Supplemental Figure S3) .
These results are qualitatively congruent with several prior findings using parenteral injections or inhalation of THC. For example, adult female rats (intact or gonadectomized) develop tolerance to THC to a greater extent than males, even with a lower per-injection dose (Wakley et al, 2015) . Tolerance to the acute locomotor stimulant effects of injected THC developed more rapidly in adolescent female rats compared with adult male rats (Wiley et al, 2011) and locomotor tolerance to THC injections was approximately equivalent in adolescent male and female rats after 9 days of repeated THC injection (Wiley and Burston, 2014) . Our prior work found female adult rats became tolerant after a repeated THC vapor inhalation regimen that did not produce tolerance in male adults . Although females were not assessed, adult male rats exposed to repeated marijuana smoke did not exhibit cross-tolerance to the locomotor suppressing effects of the endogenous cannabinoid agonist anandamide (Bruijnzeel et al, 2016) . The finding of significantly lower bodyweight in the males during the second treatment week (Supplemental Figure S2 ) is similar to evidence that repeated THC injections during adolescence reduced weight gain in male and female Wistar and LongEvans rats in a 14 day treatment interval (Keeley et al, 2015) and in male Wistar rats during an 8 day repeatedinjection study (Sofia et al, 1974) .
The present findings are likely mechanistically attributable, at least in part, to plasticity in the expression and/or function of the endogenous cannabinoid receptor subtype 1 (CB 1 ). One prior study of the effects of repeated adolescent THC exposure found decreased CB 1 receptor expression in the hippocampus of female, but not male rats (Weed et al, 2016) . Another study found greater CB 1 receptor desensitization in adolescents, compared with adults, and in female adolescents compared with male adolescents, following repeated THC injection. Changes were found in several brain regions including, importantly for the present thermoregulatory data, hypothalamus (Burston et al, 2010) .
Lasting behavioral effects of adolescent THC exposure are sometimes, but not always, found. Prior studies have identified decreased bodyweight (Rubino et al, 2008) , impaired spatial working memory (Rubino et al, 2009) , and greater sensitivity to THC on a learning task (Winsauer et al, 2011) in the wake of repeated adolescent THC exposure. In contrast, repeated THC injection (3.2 mg/kg; 8 days) during adolescence did not affect THC place or taste conditioning in adulthood (Wakeford et al, 2016) . Some prior studies have reported lasting motivational consequences of repeated adolescent THC injection, however the two available studies regarding the effect of repeated adolescent THC exposure on heroin self-administration reached different conclusions. One study in male Wistar rats utilized an injection regimen of twice per day in an escalating regimen of 2.5mg/kg from PND 35-37, 5 mg/kg from PND 38-41 and finally 10 mg/kg from PND42-45 (Stopponi et al, 2014) . Another study injected male Long-Evan rats with THC (1.5 mg/kg, i.p.) every third day from PND 28-49 (Ellgren et al, 2007) . Ellgren and colleagues reported increased heroin self-administration in the repeated-THC group when evaluated as adults during acquisition as well as in a post-acquisition dosesubstitution procedure under a FR1 contingency. In contrast, Stopponi and colleagues found no differences in the acquisition of intravenous heroin self-administration. The results in the present study are consistent with the latter study and future work could determine if intermittency of exposure, overall dose, specific opioid drug or some other factors are responsible for the differences. Due to a limited number of prior studies and varying THC exposure regimens used it is not possible to draw strong conclusions about the lasting motivational consequences of repeated adolescent exposure at this time. In the a related aspect of the present study, feeding behavior was altered with the repeated-THC males consuming more food in 6 h focal feeding sessions compared with their repeated-PG control group. It will be interesting to determine in future studies if this reflects a motivational change akin to that reported for heroin self-administration by Ellgren and colleagues.
Conclusions
The e-cigarette based vapor-inhalation method is effective for the repeated daily exposure of adolescent rats, generating physiologically significant THC exposure on each session. The exposure regimen selected here produced substantial tolerance in the female adolescents but not in the males, consistent with a sex difference found previously with repeated THC injections. There are also lasting consequences of adolescent exposure on the adult animal including thermoregulatory tolerance in each sex and a feeding phenotype in male rats. This new approach has many advantages including that it avoids the stressor of repeated parenteral injection, entails improved face validity given human cannabis use and may provide improved pharmacokinetic fidelity with human exposure patterns.
